Request for Information on the Development of the FY 2021-2023 Trans-NIH Plan for HIV-Related Research

Notice Number: NOT-OD-18-185

Key Dates
Release Date:   June 5, 2018

Related Announcements

Issued by
Office of AIDS Research (OAR)


Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, community, and other interested constituents on the development of the fiscal year (FY) 2021 - 2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research (the Plan).  The Plan is designed to identify and articulate future directions to maximize the NIH’s investments in HIV research.


This RFI is in accordance with the OAR mission to end the HIV/AIDS pandemic and improve the lives of people living with or at risk of acquiring HIV.  As legislatively mandated, OAR plans and coordinates research through the development of an annual Trans-NIH Strategic Plan for HIV and HIV-Related Research that articulates the overarching HIV research priorities and serves as the framework for developing the trans-NIH HIV research budget.  OAR oversees and coordinates the conduct and support of all HIV research activities across the NIH Institutes and Centers (ICs).  The NIH-sponsored HIV research programs include both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social sciences, and translational research on HIV and its associated coinfections and comorbidities. 

The Plan provides information about the NIH’s HIV research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broad public at large.  The fiscal year 2018 Trans-NIH Plan for HIV-Related Research was recently distributed on the OAR website: (

The current overarching priorities for HIV/AIDS research are defined in the NIH Director’s Statement of August 12, 2015 and Guide Notice NOT-OD-15-137 (

High Priority topics of research for support include:

1) Reducing the incidence of HIV/AIDS
2) Developing the next generation of HIV therapies
3) Identifying strategies towards a cure
4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and complications
5) Cross-cutting areas that includes basic research, behavioral and social sciences research, health disparities, trainings, capacity-building and infrastructure.

Information Requested
The OAR is seeking input on new and/or emerging areas of scientific investigation to inform the development of the fiscal years 2021 – 2023 Trans-NIH Plan for HIV-Related Research. Your requested feedback will assist in informing the NIH HIV/AIDS research agenda. 
Please provide your perspective on the following:

1.) Emerging areas of science in HIV/AIDS prevention, treatment, disease progression and cure that may impact the NIH research priorities.

2.) The OAR is interested in receiving input to guide NIH research investments to end the pandemic and improve the health outcomes for people living with or at risk for HIV infection. Please provide feedback on the questions below for consideration by the NIH;

a) Research gaps and promising opportunities
b) Relevant scientific developments
c) Major accomplishments that should be considered in the development of the plan

3.) Critical training and capacity-building needs that are vital to support HIV/AIDS-related research activities in support of key NIH-funded domestic and global programs.

Submitting a Response

This Office of AIDS Research RFI is open for public comment from [05/21/2018 to 06/20/2018 – 30 days].  Comments must be submitted by [11:59pm EDT on 06/20/2018].  After the public comment period has closed, all feedback received will be considered by the Office of AIDS Research in the development of the Trans-NIH Plan for HIV for HIV-Related Research.

Responses may be submitted electronically to:


Responses to this RFI Notice are voluntary.  The submitted information will be reviewed by NIH staff and may be made available to the public.  Submitted information will not be considered confidential.  This request is for information and planning purposes and should not be construed as a solicitation or as an obligation of the federal government or the NIH.  No awards will be made based on responses to this Request for Information.  The information submitted will be analyzed and may be used in reports or presentations.  Those who respond are advised that the NIH is under no obligation to acknowledge receipt of your comments or provide comments on your submission.  No proprietary, classified, confidential and/or sensitive information should be included in your response.  The NIH and the government reserve the right to use any non-proprietary technical information in any future solicitation(s).


Please direct all inquiries to:

Office of AIDS Research
National Institutes of Health